Critical Requirements In Sourcing Comparator Drugs
Source: AmerisourceBergen World Courier
![iStock-1002126898-graph-tablet-meeting-risks-planning iStock-1002126898-graph-tablet-meeting-risks-planning](https://vertassets.blob.core.windows.net/image/6268a7e7/6268a7e7-160f-4005-833d-049ad7e02fe9/375_250-istock_1002126898_graph_tablet_meeting_risks_planning.jpg)
Throughout the clinical supply chain, the logistics involved in sourcing comparator drugs, managing clinical trial supplies, maintaining precise temperature requirements and coordinating transport and storage has grown increasingly complex – and has only been exacerbated by the impact of COVID-19.
Sourcing comparator drugs and co-therapies can result in substantial delays and increased study cycle time. Planning and managing decentralized global sourcing activity poses logistical challenges — particularly with comparator drugs and co-therapies requiring strictly specified storage and shipping requirements.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
AmerisourceBergen World Courier
This website uses cookies to ensure you get the best experience on our website. Learn more